These effects protect cells from oxidative stress and enhance tissue recovery in injured or aging tissues 3
Soares MP, Teixeira L, Moita LF (2017) Disease tolerance and immunity in host protection against infection
Data that did not have a normal distribution were analysed using the Wilcoxon signed-rank test
ABSTRACT: The past decade has brought several new developments in the treatment of type 2 diabetes, including the glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
These improvements correlate with weight loss but appear partly independent of it, suggesting direct metabolic benefits
Some GLP-1 medications have demonstrated cardiovascular benefits in clinical trials (such as LEADER for liraglutide, SUSTAIN-6 for semaglutide, and REWIND for dulaglutide), and discontinuation may result in loss of these protective effects